- Home
- FBRX vs GHY Comparison
FBRX vs GHY Comparison
Compare FBRX & GHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FBRX | GHY |
|---|---|---|
| Founded | N/A | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 487.2M | 494.8M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | FBRX | GHY |
|---|---|---|
| Price | $17.84 | $11.76 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $67.00 | N/A |
| AVG Volume (30 Days) | ★ 225.5K | 104.6K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.58% |
| EPS Growth | ★ 61.30 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $36,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.12 | $11.25 |
| 52 Week High | $35.80 | $13.72 |
Technical Indicators
Market Signals| Indicator | FBRX | GHY |
|---|---|---|
| Relative Strength Index (RSI) | 40.37 | 43.33 |
| Support Level | $17.33 | $11.25 |
| Resistance Level | $22.84 | $12.10 |
| Average True Range (ATR) | 1.34 | 0.11 |
| MACD | 0.34 | -0.01 |
| Stochastic Oscillator | 45.44 | 11.59 |
Price Performance
Historical ComparisonAbout FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
About GHY PGIM Global High Yield Fund Inc.
PGIM Global High Yield Fund, Inc is a diversified, closed-end management investment company. The fund's investment objective is to provide a high level of current income. The fund seeks to provide a high level of current income by investing in higher-rated, below-investment-grade fixed income instruments of issuers located around the world, including emerging markets.